A new study suggests that adding common bone loss drugs to azoles can improve efficacy when treating fungal infections. Human skin, hair and nails are all vulnerable to fungal infections. While these ...

The decision was based on an interim analysis of the phase 3 Opera-T study, conducted after around half of the patients had ...

Please provide your email address to receive an email when new articles are posted on . Azole-resistant Aspergillus fumigatus has become an increasing problem worldwide over the last decade.

After living with a severe fungal allergy for about 40 years, Jill Fairweather is running out of treatment options. Now 65, Fairweather was diagnosed with aspergillosis, a disease caused by the common ...

Pharmaceutical firms are making progress in addressing the need for new antifungal therapies. F2G says olorofim is part of the first new class of antifungals to be developed in 20 years. F2G’s chief ...

Dermatophytes are fungi that cause skin, hair and nail fungal infections. These infections often develop resistance to azoles, a common anti-fungal treatment. A new study suggests that adding common ...